Cell-specific delivery of genes is an attractive and desirable strategy for inherited rare diseases for its potential curative outcomes. Thus, adeno-associated virus (AAV) vectors have been increasingly used as delivery vehicles for developing gene therapies. Although AAVs have ...Learn More
Inherited Retinal Diseases (IRDs) are a genetically heterogeneous group of conditions often leading to progressive vision loss and affecting different retinal cell types (Cremers et al. 2018, Toualbi et al. 2021). A gene therapy approach to improve vision relies on the delivery of ...Learn More
The CRISPR/Cas13 family consists of four nuclease subtypes, Cas 13a-d. Unlike CRISPR/Cas9 and CRISPR/Cas12, which target DNA, CRISPR/Cas13 is guided by RNA to target specific RNA sequences for degradation. In addition to targeted RNA degradation, Cas13 leads to “collateral RNA ...Learn More
cPass™ Neutralizing Antibody Detection for COVID-19 Post Vaccination Monitoring
An Antibody Drug Conjugate (ADC) is a vector-based chemotherapy that relies on the use of a monoclonal antibody (mAb) linked to an anticancer cytotoxic drug (DeCarvalho et al. 1964). Unlike conventional chemotherapy methods, ADCs can selectively target diseased cells, minimizing ...Learn More
This guy hasn’t publications anything yet.